The policy provides coverage for SI joint denervation for patients diagnosed with chronic sacroiliac joint pain. The new policy went into effect on July 28.
SInergy is a minimally invasive treatment that targets pain generating nerves in the low back and buttock region responsible for sacroiliac joint pain.
More Articles on Pain Management:
Miami’s Center for Regenerative Medicine Introduces Genorthix System for Joint Health
Hollywog Receives FDA Clearance for Back Pain Device
World Congress on Pain to Feature Neuropathic & Cancer Pain
